Contact

All Stories

  1. Impact of nutritional interventions on quality of life in schizophrenia spectrum disorders: a scoping review

    Article • Irish Journal of Psychological Medicine, March 2025, Cambridge University Press

    Dr Melanie Föcking

  2. Plasma levels of matrix metalloproteinases in early psychosis, anxiety and depression: Evidence from the ALSPAC cohort

    Article • Brain Behavior and Immunity, February 2025, Elsevier

    Dr Melanie Föcking

  3. Cannabis use in youth is associated with chronic inflammation

    Article • Psychological Medicine, December 2024, Cambridge University Press

    Dr Melanie Föcking

  4. Complement C4, C4A and C4a – What they do and how they differ

    Article • Brain Behavior & Immunity - Health, August 2024, Elsevier

    Dr Melanie Föcking

  5. Plasma complement and coagulation proteins as prognostic factors of negative symptoms: An analysis of the NAPLS 2 and 3 studies

    Article • Brain Behavior and Immunity, July 2024, Elsevier

    Dr Melanie Föcking

  6. Sample processing time but not storage time affects complement activation markers C4a, C4d, C3a, iC3b, Bb, C5a, and sC5b-9 levels in EDTA-plasma of individuals at clinical high-risk for psychosis

    Article • Biomarkers in Neuropsychiatry, June 2024, Elsevier

    Dr Melanie Föcking

  7. Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptoms

    Article • Brain Behavior and Immunity, March 2024, Elsevier

    Dr Melanie Föcking

  8. Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study

    Article • Schizophrenia Bulletin, January 2024, Oxford University Press (OUP)

    Dr Melanie Föcking

  9. Prognostic models predicting transition to psychotic disorder using blood-based biomarkers: a systematic review and critical appraisal

    Article • Translational Psychiatry, October 2023, Springer Science + Business Media

    Dr Melanie Föcking

  10. Complement proteins are elevated in blood serum but not CSF in clinical high-risk and antipsychotic-naïve first-episode psychosis

    Article • Brain Behavior and Immunity, October 2023, Elsevier

    Dr Melanie Föcking

  11. Associations between plasma inflammatory markers and psychotic disorder, depressive disorder and generalised anxiety disorder in early adulthood: A nested case-control study

    Article • Brain Behavior and Immunity, July 2023, Elsevier

    Dr Melanie Föcking

  12. Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical Trial

    Article • Schizophrenia Bulletin, March 2023, Oxford University Press (OUP)

    Dr Melanie Föcking

  13. Functional impairment of cortical AMPA receptors in schizophrenia

    Article • Schizophrenia Research, November 2022, Elsevier

    Dr Melanie Föcking

  14. Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis

    Article • Translational Psychiatry, October 2022, Springer Science + Business Media

    Dr Melanie Föcking

  15. Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case-control study of the ALSPAC cohort

    Article • Translational Psychiatry, September 2022, Springer Science + Business Media

    Dr Melanie Föcking

  16. Machine learning based prediction and the influence of complement – Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial

    Article • Brain Behavior and Immunity, July 2022, Elsevier

    Dr Melanie Föcking

  17. The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial

    Article • Brain Behavior and Immunity, January 2022, Elsevier

    Dr Melanie Föcking

  18. Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis

    Article • Molecular Psychiatry, July 2021, Springer Science + Business Media

    Dr Melanie Föcking

  19. Omega‐3 fatty acid in ultra‐high‐risk psychosis: A systematic review based on functional outcome

    Article • Early Intervention in Psychiatry, March 2021, Wiley

    Dr Melanie Föcking

  20. Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence

    Article • JAMA Psychiatry, January 2021, American Medical Association (AMA)

    Professor Anita Riecher-Rössler, Dr Melanie Föcking

  21. Adolescent-onset and adult-onset schizophrenia: reduced ribosomal protein expression via mTOR signalling in patient-derived olfactory cells

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Dr Melanie Föcking

  22. Peripheral complement proteins in schizophrenia: A systematic review and meta-analysis of serological studies

    Article • Schizophrenia Research, August 2020, Elsevier

    Dr Melanie Föcking

  23. Role of inflammation in the pathogenesis of schizophrenia: A review of the evidence, proposed mechanisms and implications for treatment

    Article • Early Intervention in Psychiatry, July 2019, Wiley

    Dr Melanie Föcking

  24. ApoE elevation is associated with the persistence of psychotic experiences from age 12 to age 18: Evidence from the ALSPAC birth cohort

    Article • Schizophrenia Research, July 2019, Elsevier

    Dr Melanie Föcking

  25. Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and Children

    Article • Biological Psychiatry, July 2019, Elsevier

    Dr Melanie Föcking

  26. Complement pathway changes at age 12 are associated with psychotic experiences at age 18 in a longitudinal population-based study: evidence for a role of stress

    Article • Molecular Psychiatry, January 2019, Springer Science + Business Media

    Dr Melanie Föcking

  27. S90. Social Defeat Stress: A Plasma Proteomic Study to Identify Stress Susceptible-Associated and Resilience-Associated Biomarkers

    Article • Biological Psychiatry, May 2018, Elsevier

    Dr Melanie Föcking

  28. F161. Proteomic Analysis of Blood Based Samples From the OPTiMiSE (OPtimization of Treatment and Management of Schizophrenia in Europe) Study Point Towards Complement Pathway Protein Changes

    Article • Biological Psychiatry, May 2018, Elsevier

    Dr Melanie Föcking

  29. The Effects of Prenatal Iron Deficiency and Risperidone Treatment on the Rat Frontal Cortex:  A Proteomic Analysis

    Article • PROTEOMICS, September 2017, Wiley

    Dr Melanie Föcking

  30. Blood-Based Protein Changes in Childhood Are Associated With Increased Risk for Later Psychotic Disorder: Evidence From a Nested Case–Control Study of the ALSPAC Longitudinal Birth Cohort

    Article • Schizophrenia Bulletin, July 2017, Oxford University Press (OUP)

    Dr Melanie Föcking

  31. Human brain proteome in health and disease

    Article • PROTEOMICS - CLINICAL APPLICATIONS, December 2016, Wiley

    Dr Melanie Föcking

  32. Blood biomarker discovery in drug-free schizophrenia: the contribution of proteomics and multiplex immunoassays

    Article • Expert Review of Proteomics, November 2016, Taylor & Francis

    Dr Melanie Föcking

  33. Proteomic analysis of the postsynaptic density implicates synaptic function and energy pathways in bipolar disorder

    Article • Translational Psychiatry, November 2016, Springer Science + Business Media

    Dr Melanie Föcking

  34. Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?

    Article • BMC Psychiatry, September 2016, Springer Science + Business Media

    Dr Melanie Föcking

  35. Abstracts from the 5th International Conference for Healthcare and Medical Students (ICHAMS)

    Article • BMC Proceedings, July 2016, Springer Science + Business Media

    Dr Melanie Föcking

  36. Dataset of mouse hippocampus profiled by LC–MS/MS for label-free quantitation

    Article • Data in Brief, June 2016, Elsevier

    Dr Melanie Föcking

  37. Proteome and pathway effects of chronic haloperidol treatment in mouse hippocampus

    Article • PROTEOMICS, January 2016, Wiley

    Dr Melanie Föcking

  38. Reduced protein synthesis in schizophrenia patient-derived olfactory cells

    Article • Translational Psychiatry, October 2015, Springer Science + Business Media

    Dr Melanie Föcking

  39. Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: Potential roles in GABAergic interneuron pathology

    Article • Schizophrenia Research, September 2015, Elsevier

    Dr Melanie Föcking

  40. Maternal Immune Activation Induces Changes in Myelin and Metabolic Proteins, Some of Which Can Be Prevented with Risperidone in Adolescence

    Article • Developmental Neuroscience, January 2015, Karger Publishers

    Dr Melanie Föcking

  41. Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia

    Article • Molecular Psychiatry, July 2014, Springer Science + Business Media

    Dr Melanie Föcking

  42. Adolescent Risperidone treatment alters protein expression associated with protein trafficking and cellular metabolism in the adult rat prefrontal cortex

    Article • PROTEOMICS, May 2014, Wiley

    Dr Melanie Föcking

  43. Poster #T144 INTEGRATED GENOMIC AND PROTEOMIC EVIDENCE FOR THE POSTSYNAPTIC DENSITY IN SCHIZOPHRENIA

    Article • Schizophrenia Research, April 2014, Elsevier

    Dr Melanie Föcking

  44. Poster #T75 PRENATAL EXPOSURE TO MATERNAL IMMUNE STIMULATION LEADS TO CHANGES IN MYELIN PROTEINS IN THE ADULT RAT PREFRONTAL CORTEX WHICH CAN BE PREVENTED BY RISPERIDONE IN ADOLESENCE

    Article • Schizophrenia Research, April 2014, Elsevier

    Dr Melanie Föcking

  45. SIGNIFICANT DOWN-REGULATION OF EIF2 AND ASSOCIATED RIBOSOMAL PROTEINS IN ONS CELL MODEL OF SCHIZOPHRENIA

    Article • Schizophrenia Research, April 2014, Elsevier

    Dr Melanie Föcking

  46. Insights from Proteomic Studies on Schizophrenia Preclinical Models: What Can We Learn for Drug Discovery?

    Article • January 2014, Karger Publishers

    Dr Melanie Föcking

  47. Proteomic Investigation of the Hippocampus in Prenatally Stressed Mice Implicates Changes in Membrane Trafficking, Cytoskeletal, and Metabolic Function

    Article • Developmental Neuroscience, January 2014, Karger Publishers

    Dr Melanie Föcking

  48. Omega-3 fatty acid deficiency disrupts endocytosis, neuritogenesis, and mitochondrial protein pathways in the mouse hippocampus

    Article • Frontiers in Genetics, January 2013, Frontiers

    Dr Melanie Föcking

  49. Proteomic analysis of human hippocampus shows differential protein expression in the different hippocampal subfields

    Article • PROTEOMICS, August 2012, Wiley

    Dr Melanie Föcking

  50. CLATHRIN-MEDIATED-ENDOCYTOSIS AND CLATHRIN-DEPENDENT MEMBRANE AND PROTEIN TRAFFICKING; CORE PATHOPHYSIOLOGICAL PROCESSES IN SCHIZOPHRENIA AND BIPOLAR DISORDER?

    Article • Schizophrenia Research, April 2012, Elsevier

    Dr Melanie Föcking

  51. Poster #135 MYELIN PATHOLOGYAND ITS RELATIONSHIP TO IRON HOMEOSTASISIN SCHIZOPHRENIA

    Article • Schizophrenia Research, April 2012, Elsevier

    Dr Melanie Föcking

  52. Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?

    Article • Molecular Psychiatry, October 2011, Springer Science + Business Media

    Dr Melanie Föcking

  53. Common Proteomic Changes in the Hippocampus in Schizophrenia and Bipolar Disorder and Particular Evidence for Involvement of Cornu Ammonis Regions 2 and 3

    Article • Archives of General Psychiatry, May 2011, American Medical Association (AMA)

    Dr Melanie Föcking

  54. The 2nd Schizophrenia International Research Society Conference, 10–14 April 2010, Florence, Italy: Summaries of oral sessions

    Article • Schizophrenia Research, December 2010, Elsevier

    Dr Melanie Föcking, Dr. Renan Pedra de Souza

  55. PROTEOMIC ANALYSIS OF HIPPOCAMPAL SUB-REGIONS IN SCHIZOPHRENIA AND BIPOLAR DISORDER REVEALS MOST PROMINENT CHANGES IN CA2/3 AND IMPLICATES ABNORMALITIES IN CLATHRIN MEDIATED ENDOCYTOSIS

    Article • Schizophrenia Research, April 2010, Elsevier

    Dr Melanie Föcking

  56. PROTEOMIC ANALYSIS OF THE BASIC SUB-PROTEOME (PH 6-11) IN THE HIPPOCAMPUS IN SCHIZOPHRENIA AND BIPOLAR AFFECTIVE DISORDER

    Article • Schizophrenia Research, April 2010, Elsevier

    Dr Melanie Föcking

  57. 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease

    Article • PROTEOMICS, June 2009, Wiley

    Dr Melanie Föcking

  58. Hepatocyte Growth Factor/c-MET Axis-mediated Tropism of Cord Blood-derived Unrestricted Somatic Stem Cells for Neuronal Injury

    Article • Journal of Biological Chemistry, July 2008, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Melanie Föcking

  59. A proteomic investigation of similarities between conventional and herbal antidepressant treatments

    Article • Journal of Psychopharmacology, June 2008, SAGE Publications

    Dr Melanie Föcking

  60. PROTEOMIC AND WESTERN BLOT ANALYSIS OF HIPPOCAMPAL SUBREGIONS IN SCHIZOPHRENIA AND BIPOLAR DISORDER

    Article • Schizophrenia Research, June 2008, Elsevier

    Dr Melanie Föcking

  61. Proteomics Providing Insights into Major Psychiatric Disorders

    Article • April 2008, Wiley

    Dr Melanie Föcking

  62. 2-D DIGE as a quantitative tool for investigating the HUPO Brain Proteome Project mouse series

    Article • PROTEOMICS, September 2006, Wiley

    Dr Melanie Föcking

  63. Caffeine-mediated enhancement of glucocorticoid receptor activity in human osteoblastic cells

    Article • Biochemical and Biophysical Research Communications, November 2005, Elsevier

    Dr Melanie Föcking

  64. Statins potentiate caspase-3 activity in immortalized murine neurons

    Article • Neuroscience Letters, January 2004, Elsevier

    Dr Melanie Föcking

  65. Host-Dependent Tumorigenesis of Embryonic Stem Cell Transplantation in Experimental Stroke

    Article • Journal of Cerebral Blood Flow & Metabolism, July 2003, SAGE Publications

    Dr Melanie Föcking

  66. Chronic glucocorticoid receptor activation impairs CREB transcriptional activity in clonal neurons

    Article • Biochemical and Biophysical Research Communications, May 2003, Elsevier

    Dr Melanie Föcking

  67. Monitoring of implanted stem cell migration in vivo : A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat

    Article • Proceedings of the National Academy of Sciences, November 2002, Proceedings of the National Academy of Sciences

    Dr Melanie Föcking

  68. Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications.

    Article • Journal of Clinical Investigation, June 1998, American Society for Clinical Investigation

    Dr Melanie Föcking